News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Tia Cheunkarndee: Our work on first line osimertinib for uncommon ex19del and compound EGFRm in NSCLC!
Photo taken from Tia Cheunkarndee/LinkedIn
May 20, 2024, 08:02

Tia Cheunkarndee: Our work on first line osimertinib for uncommon ex19del and compound EGFRm in NSCLC!

Tia Cheunkarndee, Medical Student at the Johns Hopkins University School of Medicine, shared a post on LinkedIn:

“So excited to share our work on 1L osimertinib for uncommon ex19del and compound EGFRm in NSCLC! Huge thanks to Susan Scott, Kristen A. Marrone, Matthew Guo, Johns Hopkins Thoracic Oncology for their mentorship on this project.”

Tia Cheunkarndee

Read further.
Source: Tia Cheunkarndee/LinkedIn

cancer Johns Hopkins Thoracic Oncology Kristen A. Marrone Matthew Guo NSCLC OncoDaily Oncology Susan Scott Tia Cheunkarndee
Special Coverage
Opinion
Feb 28, 2025, 18:34
Does Sunscreen Cause Cancer? Myths and Facts about Sunscreen and Cancer
Blog
Feb 28, 2025, 15:34
Cancer World welcomes their Co-Editors-in-Chief
Blog
Feb 28, 2025, 15:33
PTCy-based GVH disease prophylaxis for matched sibling donor - IACH
Blog
Feb 28, 2025, 15:25
NanCI: Connecting Scientists Gets New Features - Train at NCI
Blog
Feb 28, 2025, 15:22
Javier Cortes about value of global collaboration at EIOC 2024
Blog
Feb 28, 2025, 15:20
Dr. Tori Willard Early Career Award: Call for Proposals - SIOP
Blog
Feb 28, 2025, 15:13
Lucas’s journey with acute lymphoblastic leukemia - St. Baldrick's Foundation
Blog
Feb 28, 2025, 15:12
Catherine Alix-Panabières: Honored to welcome Key International Experts in Liquid Biopsy from 14 different countries
Blog
Feb 28, 2025, 15:02
Best registration rates for ESMO Breast 25 before 6 March
Blog
Feb 28, 2025, 14:50
Elvina Almuradova: The FDA has granted fast track designation to 67Cu-SAR-bisPSMA for PSMA-positive mCRPC
Science
Feb 28, 2025, 14:43
Drew Moghanaki: Why there is a desire to deliver SBRT to ultra-central tumors
Science
Feb 28, 2025, 14:37
Yan Leyfman: Promising Results for Sickle Cell Transplant